J. Thomas Grayston

J. Thomas Grayston's AcademicInfluence.com Rankings

J. Thomas Grayston

Philosophy

#4057

World Rank

#6435

Historical Rank

Logic

#1598

World Rank

#2395

Historical Rank

philosophy Degrees

Download Badge

Philosophy

J. Thomas Grayston's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is J. Thomas Grayston Influential?

(Suggest an Edit or Addition)

(See a Problem?)

J. Thomas Grayston's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases (1990) (902)
Chlamydia pneumoniae (TWAR) (1995) (846)
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. (1993) (808)
A NEW RESPIRATORY TRACT PATHOGEN: CHLAMYDIA PNEUMONIAE STRAIN TWAR (1990) (796)
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. (1986) (709)
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. (1970) (526)
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. (1992) (473)
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). (1995) (397)
Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR (1989) (396)
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. (1993) (382)
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. (1995) (366)
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. (1995) (365)
Azithromycin for the secondary prevention of coronary events. (2005) (359)
New knowledge of chlamydiae and the diseases they cause. (1975) (358)
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. (1997) (322)
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. (2000) (317)
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. (1998) (305)
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. (2005) (300)
Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. (1993) (283)
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. (1985) (274)
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. (1999) (268)
Murine models of Chlamydia pneumoniae infection and atherosclerosis. (1997) (267)
INCREASED FREQUENCY OF SERUM ANTIBODIES TO CHLAMYDIA TRACHOMATIS IN INFERTILITY DUE TO DISTAL TUBAL DISEASE (1982) (262)
Importance of reinfection in the pathogenesis of trachoma. (1985) (261)
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. (1993) (256)
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. (1991) (247)
Infections caused by Chlamydia pneumoniae strain TWAR. (1992) (232)
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. (1997) (226)
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. (1988) (223)
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. (1974) (222)
Pneumonia associated with the TWAR strain of Chlamydia. (1987) (217)
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. (1985) (198)
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody (1975) (192)
An epidemic of infections due to Chlamydia pneumoniae in military conscripts. (1993) (192)
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. (1998) (189)
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. (1992) (179)
Epidemiology of Mycoplasma pneumoniae infection in families. (1966) (177)
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. (1970) (174)
Chlamydia pneumoniae, strain TWAR. (1989) (172)
Chlamydia pneumoniae and cardiovascular disease. (1997) (172)
Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. (2000) (169)
Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. (1980) (161)
Identification of a new group of Chlamydia psittaci strains called TWAR (1986) (161)
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. (2000) (149)
Chlamydia pneumoniae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults: The Cardiovascular Health Study (2000) (149)
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. (1990) (148)
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. (1972) (148)
Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. (1991) (146)
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. (2000) (141)
EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS. (1965) (140)
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. (1989) (132)
Detection of Chlamydia pneumoniae by polymerase chain reaction (1992) (132)
MYCOPLASMA PNEUMONIAE INFECTIONS. CLINICAL AND EPIDEMIOLOGIC STUDIES. (1965) (129)
Trachoma vaccine studies in monkeys. (1967) (129)
Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques (1993) (129)
Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. (1995) (124)
A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis (1993) (123)
Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. (1973) (123)
Vaginal Douching as a Risk Factor for Acute Pelvic Inflammatory Disease (1993) (120)
Chlamydia pneumoniae, strain TWAR pneumonia. (1992) (119)
Radical changes to chlamydial taxonomy are not necessary just yet. (2001) (117)
Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. (1989) (113)
Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. (1997) (110)
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. (1995) (108)
Deoxyribonucleic Acid Relatedness of Chlamydia sp. Strain TWAR to Chlamydia trachomatis and Chlamydia psittaci (1988) (107)
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period. (1973) (107)
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization (1987) (106)
Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. (1991) (106)
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR (1987) (105)
Serological response to Chlamydia pneumoniae infection (1990) (103)
Experimental rabbit models of Chlamydia pneumoniae infection. (1996) (102)
Structural and antigenic analysis of Chlamydia pneumoniae (1990) (100)
Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. (1999) (99)
Effect of Polycations, Polyanions, and Neuraminidase on the Infectivity of Trachoma-Inclusion Conjunctivitis and Lymphogranuloma Venereum Organisms in HeLa Cells: Sialic Acid Residues as Possible Receptors for Trachoma-Inclusion Conjunctivitis (1973) (99)
Chlamydia pneumoniae, strain TWAR and atherosclerosis. (1993) (98)
Chronic Chlamydia trachomatis infections in infants. (1992) (92)
Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. (1988) (92)
A Simplified Method for Immunological Typing of Trachoma-Inclusion Conjunctivitis-Lymphogranuloma Venereum Organisms (1973) (90)
In vitro drug susceptibility of Chlamydia sp. strain TWAR (1988) (89)
Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. (1989) (89)
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR (1988) (89)
Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. (1990) (87)
Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. (1966) (83)
Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test (1979) (81)
Chlamydia pneumoniae (TWAR) infections in children (1994) (80)
Sexually Transmitted Diseases and Tubal Pregnancy (1990) (79)
CLASSIFICATION OF TRACHOMA VIRUS STRAINS BY PROTECTION OF MICE FROM TOXIC DEATH. (1963) (78)
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington (1983) (76)
Antibiotic Treatment of Atherosclerotic Cardiovascular Disease (2003) (75)
TRACHOMA VACCINE STUDIES ON TAIWAN * (1962) (74)
Antimicrobial Activity of Several Antibiotics and a Sulfonamide Against Chlamydia trachomatis Organisms in Cell Culture (1977) (68)
Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. (1999) (67)
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). (1972) (66)
The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. (1978) (65)
The occurrence of histoplasmosis in epidemics; epidemiological studies. (1953) (64)
Infections with Chlamydia pneumoniae strain TWAR. (1991) (64)
Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. (1967) (63)
Field Studies of Protection from Infection by Experimental Trachoma Virus Vaccine in Preschool-Aged Children on Taiwan.∗ (1963) (61)
Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. (1999) (60)
Culture-negative endocarditis probably due to Chlamydia pneumoniae. (1990) (60)
Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. (1998) (59)
Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population. (1971) (58)
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis (1995) (57)
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. (1975) (56)
Isolation of Cytomegalovirus from a Cohort of 100 Infants Throughout the First Year of Life 1 (1969) (56)
Direct fluorescent monoclonal antibody stain for rapid detection of infant Chlamydia trachomatis infections. (1984) (56)
Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. (2000) (55)
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. (1967) (54)
Mycoplasma pneumoniae in the community. (1971) (54)
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. (1990) (51)
Chlamydia in atherosclerosis. (1993) (51)
Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. (1967) (50)
Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis (1989) (49)
Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. (1967) (49)
Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women. (1970) (48)
Transmission of Chlamydia pneumoniae in young children in a Japanese family. (1990) (48)
The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group. (1993) (47)
Trachoma-studies of etiology, laboratory diagnosis, and prevention. (1960) (47)
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. (1972) (47)
Vaginal Douching and the Risk of Tubal Pregnancy (1991) (45)
Respiratory infection withchalmydia pneumoniae in middle-aged and older adult outpatients (1994) (43)
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. (1973) (43)
Further Characterization of Chlamydia pneumoniae Specific Monoclonal Antibodies (1995) (42)
PREVENTION OF TRACHOMA WITH VACCINE. (1964) (42)
Microbial causes of neonatal conjunctivitis (1984) (42)
Acquisition of mycoplasmata and T-strains during infancy. (1970) (40)
Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. (2000) (39)
Randomized trial of silver nitrate, erythromycin, and no eye prophylaxis for the prevention of conjunctivitis among newborns not at risk for gonococcal ophthalmitis. Eye Prophylaxis Study Group. (1993) (39)
TRIC type K, a new immunologic type of Chlamydia trachomatis. (1974) (39)
Risk of perinatal transmission of Chlamydia trachomatis by mode of delivery. (1994) (39)
Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells (1988) (39)
Studies on acute respiratory illness in naval recruits, with emphasis on the adenoviruses (APC-RI). (1956) (37)
THE EFFECT OF TRACHOMA VIRUS VACCINE ON THE COURSE OF EXPERIMENTAL TRACHOMA INFECTION IN BLIND HUMAN VOLUNTEERS (1962) (37)
Antibiotic treatment trials for secondary prevention of coronary artery disease events. (1999) (37)
Childhood myocarditis associated with Chlamydia trachomatis infection. (1981) (36)
Characterization of the Group Antigen of Chlamydia trachomatis (1971) (32)
Serologic tests for Chlamydia pneumoniae. (1993) (31)
EPIDEMIC KERATOCONJUNCTIVITIS ON TAIWAN: ETIOLOGICAL AND CLINICAL STUDIES. (1964) (30)
TRACHOMA IN THE TAIWAN MONKEY, MACACA CYCLOPIS * (1962) (30)
Radiographic study of mycoplasma pneumoniae pneumonia. (1973) (30)
Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough. (1997) (29)
Current knowledge onChlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases (1989) (29)
Childhood trachoma in a nonendemic area. Danish trachoma patients and their close contacts, 1963 to 1973. (1978) (28)
Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization. (1971) (28)
Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion (1990) (28)
Chlamydia pneumoniae and cardiovascular disease. (1997) (28)
Field trial of two bivalent trachoma vaccines in children of Punjab Indian villages. (1967) (27)
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. (2000) (27)
Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice. (1998) (27)
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae (1996) (27)
Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested. (2015) (26)
Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines. (1969) (26)
Incidence of tuberculin, histoplasmin, and blastomycin reactors among a group of school children. (1953) (26)
Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis. (1991) (25)
Isolation of TRIC agents and mycoplasma from the genito-urinary tracts of patients of a venereal disease clinic. (1967) (25)
Delayed appearance of Chlamydia trachomatis infections acquired at birth. (1987) (25)
What is needed to prove that Chlamydia pneumoniae does, or does not, play an etiologic role in atherosclerosis? (2000) (25)
Does Chlamydia pneumoniae cause atherosclerosis? (1999) (25)
Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies (1991) (24)
Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues. (1999) (24)
Comparison of Ophthalmic Silver Nitrate Solution and Erythromycin Ointment for Prevention of Natally Acquired Chlamydia trachomatis (1987) (24)
Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines. (1969) (23)
Evidence that Chlamydia pneumoniae, strain TWAR, is not sexually transmitted. (1989) (23)
A potency test for trachoma vaccine utilizing the mouse toxicity prevention test. (1967) (23)
Microbial causes of neonatal conjunctivitis. (1985) (23)
Neutralizing and complement fixing antibody response to adenovirus infection. (1956) (22)
Chlamydia trachomatis immunotype J. (1975) (22)
Occurrence of histoplasmosis in epidemics; etiologic studies. (1953) (22)
Past use of erythromycin, tetracycline, or doxycycline is not associated with risk of first myocardial infarction. (2000) (22)
Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease. (1999) (22)
Adenovirus infections in Chinese Army recruits on Taiwan. (1960) (21)
Editorial response : The role of Chlamydia pneumoniae in atherosclerosis (1999) (21)
Secondary prevention antibiotic treatment trials for coronary artery disease. (2000) (21)
Local antibody in semen for rapid diagnosis of Chlamydia trachomatis epididymitis. (1988) (21)
Experimental infection of baboons (Papio cynocephalus anubis) with Chlamydia pneumoniae strain 'TWAR'. (1989) (21)
Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol (1991) (20)
Pathogenesis and immunology of trachoma. (1972) (19)
Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella. (1969) (18)
Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults. (2001) (18)
No association of chronic Chlamydia pneumoniae infection with chronic fatigue syndrome. (1992) (17)
Encephalitis on Taiwan. III. Virus isolations from mosquitoes. (1962) (17)
Adenovirus infections in naval recruits. (1959) (17)
Long term follow-up study of a trachoma vaccine trial in villages of Northern India. (1979) (17)
The epidemiology of rubella on Taiwan. I. Introduction and description of the 1957-1958 epidemic. (1972) (17)
Failure of trachoma treatment with ophthalmic antibiotics and systemic sulfonamides used alone or in combination with trachoma vaccine. (1967) (17)
The association between Chlamydia trachomatis serology and pelvic damage in women with tubal ectopic gestations (1993) (16)
Egg Infectivity Assay of Trachoma Virus.∗ (1964) (16)
Encephalitis on Taiwan. I. Introduction and epidemiology. (1960) (16)
FURTHER STUDIES WITH A COMPLEMENT FIXATION TEST FOR TRACHOMA * (1962) (16)
Serologic evidence of respiratory and rickettsial infections among Somali refugees. (1995) (16)
Chlamydia pneumoniae and atherosclerosis. (2005) (16)
ANTIGENIC RELATIONSHIPS OF TRACHOMA VIRUS STRAINS IN THE MOUSE TOXICITY PREVENTION TEST * (1962) (16)
Sensitivity and resistance of TRIC agents to penicillin, tetracycline and sulfa drugs. (1967) (15)
Serologic evidence for Chlamydia trachomatis myocarditis. (1982) (15)
An improved technique for the neutralization test with adenoviruses in HeLa cell cultures. (1956) (15)
Epidemiology of rubella on Taiwan. (1969) (15)
THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS (1997) (14)
Outbreak ofChlamydia pneumoniae infection in four farm families (1992) (14)
SYMPOSIUM ON TRACHOMA. BIOLOGY OF THE VIRUS. (1963) (14)
Pulmonary histoplasmosis in a farm family; a three-year follow-up. (1954) (13)
Trachoma virus isolation studies on Taiwan. (1962) (13)
Epidemiological studies of pulmonary histoplasmosis in a farm family. (1952) (12)
Mycoplasma pneumoniae and Chlamydia pneumoniae strain TWAR infections in U.S. Marine Corps recruits. (1994) (12)
Encephalitis on Taiwan. II. Mosquito collection and bionomic studies. (1962) (12)
Natural history of trachoma in Taiwan school children. (1967) (12)
The epidemiology of rubella on Taiwan. II. 1968-1969 epidemic. (1972) (12)
Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans (1989) (12)
The chlamydial pneumonias. (1991) (12)
Electrocardiographic response to maximal exercise (1967) (11)
Etiologic Studies of Trachoma on Taiwan.∗ (1959) (10)
Adenoviruses. II. The sensitivity of different tissue culture strains of cells to adenoviruses. (1958) (10)
Myocarditis as a Complication of Infantile Chlamydia trachomatis Pneumonitis (1983) (10)
Rapid diagnosis of Chlamydia trachomatis pneumonia in infants. (2009) (10)
Adenovirus Neutralizing Antibody Determination by Colorimetric Assay.∗ (1957) (10)
PILOT STUDY OF ISCHEMIC HEART DISEASE ON TAIWAN. SELECTION OF TWO POPULATION SAMPLES FOR A COMPARATIVE EPIDEMIOLOGIC STUDY. (1965) (10)
Adenovirus Neutralizing Antibodies in Persons on Taiwan.∗ (1962) (10)
A field trial of Hong Kong-strain influenza vaccine in Seattle schoolchildren. (1969) (10)
Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. (2003) (9)
Repeated Mycoplasma pneumoniae Pneumonia After 4 1/2 Years (1971) (9)
Growth of Japanese encephalitis virus in cell culture (1965) (9)
Adenoviruses. III. Their etiological role in acute respiratory diseases in civilian adults. (1958) (9)
The geographic distribution of histoplasmin reactors among school age children within a rural Iowa county. (1955) (9)
Chlaymydia spp. strain TWAR A newly recognized organism associated with atypical pneumonia and other respiratory infections (1988) (9)
Characterization of trachoma antigens protective against mouse toxicity. (1967) (9)
Detection of Chlamydia pneumoniae in atheroma specimens. (1996) (9)
Mycoplasmas (PPLO) in human disease (1967) (9)
Experimental histoplasmosis in mice; a preliminary report. (1956) (8)
Congenital Abnormalities Following Gestational Rubella in Chinese: Report of a Prospective Study Including Five-Year Follow-Up Examinations After the 1957-1958 Rubella Epidemic on Taiwan (Formosa) (1967) (8)
History of Chlamydia pneumoniae (TWAR) (1999) (8)
Chlamydia pneumoniaeand the Risk of First Ischemic Stroke (2000) (8)
The isolation of Histoplasma capsulatum from soil in an unused silo. (1951) (8)
Lack of evidence of Chlamydia pneumoniae infection in infants with acute lower respiratory tract disease. (1993) (7)
Encephalitis on Taiwan. V. Animal and bird serology. (1962) (7)
Serological Relationship of Trachoma, Psittacosis and Lymphogranuloma Venereum Viruses.∗ (1960) (7)
Electrocardiographic response to maximal exercise. Treadmill and double master exercise tests in middle-aged Chinese men. (1967) (7)
Encephalitis of Taiwan. IV. Human serology. (1962) (7)
Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines. (1971) (7)
Experimental histoplasmosis in immunized and nonimmunized mice; comparative pathology. (1956) (7)
A study of the complement fixation reaction in histoplasmosis. (1952) (7)
Protective Studies in Mice and Monkeys with an Inactivated Japanese Encephalitis Virus Vaccine Grown in Hamster Diploid Cell Culture.∗ (1967) (7)
Comparative infectivity of trachoma organisms in HeLa 229 cells and egg cultures (1975) (6)
Epidemic rubella in Taiwan, 1957-1958. III. Gamma globulin in the prevention of rubella. (1959) (6)
The epidemiology of rubella on Taiwan. 3. Family studies in cities of high and low attack rates. (1972) (6)
Chlamydia pneumoniae strain TWAR pharyngitis in US Air Force basic trainees (1994) (6)
Isolation of TRIC agents and mycoplasma from the cervix of pregnant women. Preliminary results. (1967) (6)
Chlamydia pneumoniae and Mycoplasma pneumoniae infections (1996) (6)
Bacterial conjunctivitis caused by an eye ointment base used as a placebo in therapeutic trials. (1961) (5)
The role of Chlamydia pneumoniae in atherosclerosis. (1999) (5)
Adenoviruses. I. The effect of total incubation time in HeLa cell cultures on the isolation rate. (1958) (5)
Experimental histoplasmosis in immunized and nonimmunized Mice. (1956) (5)
[Prevalence of Chlamydia pneumoniae infection among pneumonias in a sample of Spanish hospital population]. (1991) (5)
Trachoma vaccine trial in India: results of two-year follow-up. (1968) (5)
Past Use of an Intrauterine Device and Risk of Tubal Pregnancy (1993) (5)
Current Knowledge of Chlamydia TWAR, an Important Cause of Pneumonia and Other Acute Respiratory Diseases (1989) (5)
Titration of Asian influenza neutralizing antibody by use of hemadsorption inhibition in tissue cultures. (1960) (5)
Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Summary and Commentary. (1986) (4)
Chlamydia Pneumoniae (TWAR) Infection in Tanzanian Children (1996) (4)
Role of Chlamydia pneumoniae (TWAR) in IgA Nephropathy (1998) (4)
Histoplasmin and tuberculin sensitivity among Illinois residents. (1953) (4)
The Frequency of Serologic Evidence of Bordetella Infections and Mixed Infections with Other Respiratory Pathogens in University Students with Cough Illnesses (1999) (4)
Further characterization of TRIC agent strains of genital origin. (1968) (3)
Encephalitis on Taiwan. VI. Infections in American servicemen on Taiwan and Okinawa. (1962) (3)
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis. (1999) (3)
Nontuberculous chest diseases: occurrence of histoplasmosis in epidemics. (1952) (3)
Repeated Mycoplasma pneumoniae pneumonia after 4 and one-half years. (1971) (3)
Micro-immunofluorescence antibody responses to trachoma vaccines (2004) (3)
[Immunization against trachoma]. (1968) (3)
Summary of a workshop on the major histocompatibility complex in infectious disease epidemiology. (1979) (3)
Recurrence of Asian variant influenza in the Far East; report of 1958 epidemic in Marine Corps on Okinawa. (1959) (3)
EPIDEMIOLOGIC STUDIES OF THE 1958 CHOLERA EPIDEMIC IN BANGKOK, THAILAND (1960) (3)
Some epidemiological and clinical aspects of pulmonary histoplasmosis in a farm family. (1952) (3)
Workshop on the major histocompatibility complex in infectious disease epidemiology. (2008) (2)
Preliminary report on field studies of trachoma vaccine on Taiwan. (1961) (2)
Chlamydia pneumoniae and atherosclerosis. (1998) (2)
Chlamydia pneumoniae,Strain TWAR, a New Important Pathogen (1991) (2)
Live attenuated rubella virus vaccine given in an orphanage just prior to a rubella epidemic. (1969) (2)
Complement fixation test for diagnosis of trachoma in India. (1960) (2)
Asian influenza in Taiwan-1958. (1960) (2)
Second Asian influenza epidemics occurring in vaccinated men aboard U.S. Navy vessels. (1959) (2)
Adenoviruses and Enteroviruses isolated from Sick Children in Taiwan. (1961) (2)
Febrile and local reactions to two highly concentrated trachoma vaccines with and without adjuvant. (1968) (1)
Titration of smallpox vaccines from ten countries sent to East Pakistan during the 1958 smallpox epidemic. (1959) (1)
Erratum: Radical changes to chlamydial taxonomy are not necessary just yet (International Journal of Systematic and Evolutionary Microbiology (2006) vol. 51 (249)) (2006) (1)
Chlamydia pneumoniae and atherosclerotic risk in populations (2000) (1)
Studies of trachoma in families on Taiwan. (1975) (1)
Future trends in Chlamydia pneumoniae research and the place of macrolides in treatment. (1996) (1)
Studies of Gastrointestinal Viral Flora of Cholera Patients.∗ † (1960) (1)
Epidemics of histoplasmosis. (1956) (1)
Bacterial conjunctivitis caused by a base eye ointment used as a placebo. (1960) (1)
Geographic distribution of histoplasmin reactors among school-age children in Jackson County, Iowa. (1956) (1)
Histoplasmin and tuberculin sensitivity among Illinois residents. (1953) (1)
Studies on delayed hypersensitivity with trachoma organisms. 3. Lymphokines. (1974) (1)
TRACHOMA INFECTIONS ON TAIWAN: EPIDEMIOLOGY, PREVENTION AND CHEMOTHERAPY STUDIES (1966) (1)
A study of the complement fixation reaction in histoplasmosis, employing whole yeast phase cells as antigen. (1956) (1)
Growth of Japanese encephalitis virus in cell structure. (1965) (1)
Tracking the TWAR Organism (1999) (1)
Epidemic Keratoconjunctivitis (E.K.C.). Part III. Adenovirus Isolation from E.K.C. (1959) (1)
Centers for Disease Control Guidelines for Prevention and Control of Chlamydia trachomatisInfections (2020) (0)
Studies in Civilian Populations1, 2 (2015) (0)
Experimental trachoma in human volunteers. (1961) (0)
Trachoma-Inclusion Conjunctivitis and Lymphogranuloma Venereum Organisms in HeLa Cells: Sialic Acid Residues (2003) (0)
Goat Red Blood Cells in Agglutination Test for Infectious Mononucleosis.∗ (1959) (0)
The Newborn: CONGENITAL ABNORMALITIES FOLLOWING GESTATIONAL RUBELLA IN CHINESE (1968) (0)
Trachoma organisms: technical advances in laboratory diagnosis. (1975) (0)
Occurrence of Histoplasmosis in Epidemics1,2 (2019) (0)
[Pleuropneumonia with abscess formation caused by TWAR]. (1988) (0)
Studies of encephalitis on Taiwan. VI. Infections in American servicemen on Taiwan and Okinawa. (1960) (0)
Titration of Asian influenza neutralizing antibody by use of hemadsorption inhibition in tissue cultures. (1961) (0)
We agree that carefully controlled treatment trials are justified as the only way to determine the etiologic role of C. pneumoniae in atherosclerosis. (1996) (0)
Journal of Infectious Disease: Preface (2000) (0)
The detection of a associated with respiratory diseases single strain of chlamydia. (1987) (0)
[The complement fixation test in trachoma patients of Eritrea]. (1960) (0)
Human Chlamydial Infections (1979) (0)
Trachoma, Studies of Etiology, Prevention and Cure. (1959) (0)
Interaction ofChlamydia trachomatis Organisms andHeLa 229Cells (1976) (0)
STUDIES OF INFECTIOUS DISEASES OF TAIWAN. (1966) (0)
Studies of encephalitis on Taiwan. VI. Infections in American servicemen on Taiwan and Okinawa. (1960) (0)
CONFIRMED PREVIOUS INFECTION WITH CHLAMYDIAE (TWAR) AND ITS PERSENCE IN EARLY CORONARY ATHEROSCLEROSIS (1998) (0)
METHODS FOR DESCRIBING BEHAVIOR OF RESPIRATORY DISEASES. STUDIES IN CIVILIAN POPULATIONS. (1963) (0)
Comment Chlamydia in Atherosclerosis (2005) (0)
The Environmental Information Partnership (EIP) for the Moose River Basin (1998) (0)
Chapter 19 Chlamydia (1998) (0)
Serological Studies of Chlamyoia Trachomatis(CT) Epioioymitis (1987) (0)
PREVENTION OF TRACHOMA WITH VACCINE. LECTURE AND REVIEW SERIES, REP NO. 63-3. (1963) (0)
Etiologic studies of trachoma on Taiwan. (1959) (0)
SYMPOSIUM ON TRACHOMA: BIOLOGY OF THE VIRUS. LECT REV SER REP NO. 63-1. (1963) (0)
Encephalitis on Taiwan. I. Introduction and epidemiology. (1962) (0)
The host in infection. (1957) (0)
Infectious contributions to atherosclerosis and vascular disease (2006) (0)
Studies on Delayed Hypersensitivity with Trachoma Organisms (1974) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With J. Thomas Grayston?

J. Thomas Grayston is affiliated with the following schools: